Oncology & Cancer

Team finds a potentially better way to treat liver cancer

A Keck School of Medicine of USC research team has identified how cancer stem cells survive. This finding may one day lead to new therapies for liver cancer, one of the few cancers in the United States with an incidence rate ...

Medical research

Peptide delays melanoma growth in animal trials

An article published in Scientific Reports describes a study demonstrating the effectiveness of a peptide developed by Brazilian scientists, called Rb4, in combating cancer progression in an animal model, especially malignant ...

Oncology & Cancer

Dioxin-like chemical messenger makes brain tumors more aggressive

A research alliance of Heidelberg University Hospital and the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ), jointly with colleagues of the Helmholtz Center for Environmental Research in Leipzig, ...

Oncology & Cancer

Feed a cold -- starve a tumor

The condition tuberous sclerosis, due to mutation in one of two tumor suppressor genes, TSC1 or TSC2, causes the growth of non-malignant tumors throughout the body and skin. These tumors can be unsightly and cause serious ...

Oncology & Cancer

New chimeric antibody that suppresses malignant cancers in dogs

Similar to humans, dogs live longer than before and an increasing number of them die from cancer. As seen in humans, dogs have malignant cancers that cannot be treated by existing therapies such as surgery, radiotherapy and ...

Medications

New promising targeted drug for a rare leukemia

Targeted drugs have been developed to supplement chemotherapy in the treatment of cancer. These drugs only affect cancer cells, leaving healthy cells alone. Venetoclax is a new targeted therapy option for the treatment of ...

page 11 from 40